Blue Owl Technology Finance Q2 Earnings Call Highlights

Blue Owl Technology Finance reported adjusted net investment income of $0.30 per share and NAV of $16.48 per share. Portfolio credit quality remained strong, with non-accruals at just 10 basis points of fair value and more than 80% of investments in senior secured loans. The company made approximately $850 million in new commitments and funded $550 million during the quarter, focusing on software while expanding into life sciences and digital infrastructure. Management said reduced lending supply has enabled wider spreads, stronger covenants and improved documentation. Net leverage ended at 0.93x, near the low end of the 0.9x–1.25x target range, while the board declared a $0.35 base dividend plus a $0.05 special dividend. Management expects further leverage and portfolio deployment to support earnings growth and eventual base-dividend coverage.

Blue Owl Technology Finance NYSE: OTF reported second-quarter adjusted net investment income of $0.30 per share and net asset value of $16.48 per share, as the business development company continued to expand its portfolio, increase leverage and repurchase shares. The company said portfolio credit performance remained strong, with non-accruals of 10 basis points of fair value at quarter-end, including one small position added during the quarter. Blue Owl said it was not seeing material signs of stress among borrowers, which it said continued to generate high-single-digit revenue and EBITDA growth.

Management said the investment environment for technology lending has become more attractive as capital availability has declined, allowing lenders to seek wider spreads, stronger covenants and improved documentation. The company expects its base dividend to be covered by the middle of next year as it deploys capital, raises leverage toward the midpoint of its target range and invests at improved market terms.

Portfolio growth and investment activity Erik Bissonnette, President of Blue Owl Technology Finance, said the company made roughly $850 million of new commitments and funded $550 million during the second quarter. Sales and repayments totaled approximately $222 million. While primary deal activity remained subdued, Bissonnette said a larger portion of new originations should benefit from the more attractive current lending environment. He said Blue Owl is also seeing opportunities to improve economics on existing investments when borrowers seek additional financing or extended maturities. “As high-quality borrowers look to raise additional capital for extended maturities, we are often able to secure wider spreads, enhanced protections, and stronger covenants,” Bissonnette said. The company said it is continuing to focus on software while pursuing additional opportunities in life sciences and digital infrastructure. Software represented about 70% of the portfolio at quarter-end. Blue Owl said its software investments are concentrated in market segments with mission-critical applications, embedded workflows and trusted data that it believes can benefit from further artificial intelligence integration. Blue Owl led a $700 million platform-wide loan for Caris, a commercial-stage company focused on cancer diagnostics, during the quarter. Life sciences represented nearly 2% of the portfolio, according to management. Management also highlighted digital infrastructure as an area of opportunity, citing the capital needs associated with data-center and GPU buildouts. Bissonnette said the firm sees potential to provide debt capital backed by mission-critical digital assets, often involving investment-grade counterparties.

Credit metrics and portfolio construction Blue Owl sa...